This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Argenx Bv. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Kevin Budding: Innovator in the Field of Biotechnology
Introduction
Kevin Budding is a notable inventor based in Vleuten, Netherlands. He is currently associated with Argenx Bv, a company that focuses on developing innovative therapies for patients with severe autoimmune diseases. Despite having no patents to his name, his contributions to the field of biotechnology are significant.
Latest Patents
As of now, Kevin Budding holds 1 patents. This may reflect his focus on collaborative research and development rather than individual patenting.
Career Highlights
Throughout his career, Kevin has been involved in various projects that aim to advance medical science. His work at Argenx Bv has allowed him to collaborate with leading experts in the field, contributing to the development of groundbreaking therapies.
Collaborations
Due to space constraints, the details of Kevin's collaborations will not be included.
Conclusion
Kevin Budding is an influential figure in biotechnology, working diligently to improve healthcare outcomes through his role at Argenx Bv. His commitment to innovation and collaboration highlights the importance of teamwork in advancing medical science.